![Ross Breckenridge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ross Breckenridge
Amministratore Delegato presso Arjuna Therapeutics
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Charlie Sheppard | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Graeme Martin | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Tamara Elias | M | 53 | 4 anni | |
Tatiana López del Río | F | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Darren Bianchi | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Robert Barnes | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Leigh F. Elkolli | F | - | - | |
Katrina L. Thompson | F | 65 | 14 anni | |
Stephen Oesterle | M | 73 | 1 anni | |
Brandi Roberts | F | 50 | 2 anni | |
Anne Jillian Keating | F | 70 | 7 anni | |
Gordon E. Nye | M | 69 | 18 anni | |
C. Larkin | M | 75 | 2 anni | |
Robert K. Schultz | M | 68 | 14 anni | |
R. Huennekens | M | 59 | 3 anni | |
Regina Groves | F | 66 | 4 anni | |
Richard Kimes | M | 62 | 2 anni | |
Donald K. Brandom | M | 64 | 13 anni | |
David Eisler | M | 45 | 1 anni | |
Joann Lofgren Yao | F | - | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 15 | 75.00% |
Spagna | 5 | 25.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Ross Breckenridge
- Contatti personali